Bears Pile Into Biotech and EV Names
Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish
Short sellers added pressure to several mid-cap stocks last week, with two biotech names and a gas producer seeing the sharpest five-day increases in short interest.
BRVE, Braveheart Bio, saw its SI % of free float climb to 46.2%. That is up from 38.0% just seven days ago, an 8.2 percentage-point jump. Bears have been steadily building since mid-October.
SRZN, Surrozen, rose even faster in relative terms. Its SI % FF hit 44.9%, up 10.7 points in five days. Gas producer BKV also attracted fresh shorts, reaching 42.7% from 38.3%.
Hertz and Wolfspeed Stay in the Crosshairs
HTZ remains one of the most shorted liquid names in the market. SI sits at 72.9% of free float. Cost to borrow has surged to 290% APR. Shares available to borrow have dropped to zero, leaving fresh short positions almost impossible to open. That combination keeps squeeze risk elevated.
WOLF, the chip maker formerly known as Wolfspeed, has 86.5% of its float sold short. Cost to borrow is low at just 2%, meaning shorts face little carry cost. EV maker LCID holds 66.2% SI with availability at a near-zero 0.09%.
NVDA Bears Stay Light Despite CEO Scandal
NVDA made headlines Monday after reports emerged about an internal investigation involving its CEO. Despite heavy social media traffic, short interest is only 1.3% of free float. Cost to borrow is 0.37%. Bears have not meaningfully added to positions.
Short Covering Flashes at Jasper Therapeutics
JSPR, Jasper Therapeutics, saw one of the sharpest short-covering moves in the market. SI dropped from 664% of free float to 15.6% in five days, suggesting a large position was unwound or shares reclassified. AXT also saw shorts trim by 4.7 points to 18.6%.
Index watchers should note that Aptiv and Alexandria Real Estate Equities face rising S&P 500 deletion odds, per ORTEX Index Rebalance Radar, which could add technical selling pressure on top of any existing short positions.
Stocks in this article
How this article was generated
- Generated
- 9 Nov 2026, 20:03
- Prompt version
- v1.0
- Data sources
- Short interestCost to borrowUtilizationAlt DataIndex Rebalance
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.